Uptake of Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in a Single Clinical Commissioning Group in England Without Restrictions to Their Use
ConclusionsThe early use of DOACs, in a CCG without restrictions to their use, was embraced by primary-care prescribers in this particular CCG.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Aspirin | Atrial Fibrillation | Coumadin | Drugs & Pharmacology | General Practices | Primary Care | Statistics | Stroke | Students | Study | Universities & Medical Training | Warfarin